A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer

Cristina Deambrogio, Isabella Castellano, Alessia Paganotti, Elisabetta Omodeo Zorini, Fabio Corsi, Riccardo Bussone, Roberto Franchini, Jlenia Antona, Umberto Miglio, Anna Sapino, Concetta Antonacci, Renzo Boldorini

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Aims: Cytokeratin 19 (CK19) mRNA copy number predicts the probability of tumour load in axillary lymph nodes (ALN) and can help in decision-making regarding the axillary dissection. The purpose of this study was to define a new cut-off of CK19 mRNA copy number using the one-step nucleic acid amplification (OSNA) assay on metastatic sentinel lymph nodes (SLN) in order to identify cases at risk of having one or more positive ALN. Methods: 1296 SLN from 1080 patients were analysed with the OSNA assay. 194 patients with positive SLN underwent ALN dissection and the mean value of CK19 copy number (320 000) of their SLN was set as initial cut-off. Receiver operative characteristics curve identify a best cut-off of 7700 (sensitivity 78%, specificity 57%). A comparison between our and the traditional cut-off (5000) was performed. Results: The cut-off of 7700 successfully identifies patients with positive ALN (p=0.001, false- negative cases: 17%). In the range between 5000 and 7700, one patient with positive ALN would not undergo axillary dissection, whereas eight patients with negative ALN would be correctly identified. Conclusions: We suggest that the level of CK19 mRNA copy number could be the only parameter to consider in the intraoperative management of the axilla.

Original languageEnglish
Pages (from-to)702-706
Number of pages5
JournalJournal of Clinical Pathology
Volume67
Issue number8
DOIs
Publication statusPublished - 2014

Fingerprint

Keratin-19
Lymph Node Excision
Lymph Nodes
Breast Neoplasms
Messenger RNA
Nucleic Acids
Dissection
Axilla
Tumor Burden
Decision Making
Sentinel Lymph Node
Sensitivity and Specificity

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer. / Deambrogio, Cristina; Castellano, Isabella; Paganotti, Alessia; Zorini, Elisabetta Omodeo; Corsi, Fabio; Bussone, Riccardo; Franchini, Roberto; Antona, Jlenia; Miglio, Umberto; Sapino, Anna; Antonacci, Concetta; Boldorini, Renzo.

In: Journal of Clinical Pathology, Vol. 67, No. 8, 2014, p. 702-706.

Research output: Contribution to journalArticle

Deambrogio, C, Castellano, I, Paganotti, A, Zorini, EO, Corsi, F, Bussone, R, Franchini, R, Antona, J, Miglio, U, Sapino, A, Antonacci, C & Boldorini, R 2014, 'A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer', Journal of Clinical Pathology, vol. 67, no. 8, pp. 702-706. https://doi.org/10.1136/jclinpath-2014-202384
Deambrogio, Cristina ; Castellano, Isabella ; Paganotti, Alessia ; Zorini, Elisabetta Omodeo ; Corsi, Fabio ; Bussone, Riccardo ; Franchini, Roberto ; Antona, Jlenia ; Miglio, Umberto ; Sapino, Anna ; Antonacci, Concetta ; Boldorini, Renzo. / A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer. In: Journal of Clinical Pathology. 2014 ; Vol. 67, No. 8. pp. 702-706.
@article{d3c9af56d5ee4923aff31c3906fc064f,
title = "A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer",
abstract = "Aims: Cytokeratin 19 (CK19) mRNA copy number predicts the probability of tumour load in axillary lymph nodes (ALN) and can help in decision-making regarding the axillary dissection. The purpose of this study was to define a new cut-off of CK19 mRNA copy number using the one-step nucleic acid amplification (OSNA) assay on metastatic sentinel lymph nodes (SLN) in order to identify cases at risk of having one or more positive ALN. Methods: 1296 SLN from 1080 patients were analysed with the OSNA assay. 194 patients with positive SLN underwent ALN dissection and the mean value of CK19 copy number (320 000) of their SLN was set as initial cut-off. Receiver operative characteristics curve identify a best cut-off of 7700 (sensitivity 78{\%}, specificity 57{\%}). A comparison between our and the traditional cut-off (5000) was performed. Results: The cut-off of 7700 successfully identifies patients with positive ALN (p=0.001, false- negative cases: 17{\%}). In the range between 5000 and 7700, one patient with positive ALN would not undergo axillary dissection, whereas eight patients with negative ALN would be correctly identified. Conclusions: We suggest that the level of CK19 mRNA copy number could be the only parameter to consider in the intraoperative management of the axilla.",
author = "Cristina Deambrogio and Isabella Castellano and Alessia Paganotti and Zorini, {Elisabetta Omodeo} and Fabio Corsi and Riccardo Bussone and Roberto Franchini and Jlenia Antona and Umberto Miglio and Anna Sapino and Concetta Antonacci and Renzo Boldorini",
year = "2014",
doi = "10.1136/jclinpath-2014-202384",
language = "English",
volume = "67",
pages = "702--706",
journal = "Journal of Clinical Pathology - Clinical Molecular Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer

AU - Deambrogio, Cristina

AU - Castellano, Isabella

AU - Paganotti, Alessia

AU - Zorini, Elisabetta Omodeo

AU - Corsi, Fabio

AU - Bussone, Riccardo

AU - Franchini, Roberto

AU - Antona, Jlenia

AU - Miglio, Umberto

AU - Sapino, Anna

AU - Antonacci, Concetta

AU - Boldorini, Renzo

PY - 2014

Y1 - 2014

N2 - Aims: Cytokeratin 19 (CK19) mRNA copy number predicts the probability of tumour load in axillary lymph nodes (ALN) and can help in decision-making regarding the axillary dissection. The purpose of this study was to define a new cut-off of CK19 mRNA copy number using the one-step nucleic acid amplification (OSNA) assay on metastatic sentinel lymph nodes (SLN) in order to identify cases at risk of having one or more positive ALN. Methods: 1296 SLN from 1080 patients were analysed with the OSNA assay. 194 patients with positive SLN underwent ALN dissection and the mean value of CK19 copy number (320 000) of their SLN was set as initial cut-off. Receiver operative characteristics curve identify a best cut-off of 7700 (sensitivity 78%, specificity 57%). A comparison between our and the traditional cut-off (5000) was performed. Results: The cut-off of 7700 successfully identifies patients with positive ALN (p=0.001, false- negative cases: 17%). In the range between 5000 and 7700, one patient with positive ALN would not undergo axillary dissection, whereas eight patients with negative ALN would be correctly identified. Conclusions: We suggest that the level of CK19 mRNA copy number could be the only parameter to consider in the intraoperative management of the axilla.

AB - Aims: Cytokeratin 19 (CK19) mRNA copy number predicts the probability of tumour load in axillary lymph nodes (ALN) and can help in decision-making regarding the axillary dissection. The purpose of this study was to define a new cut-off of CK19 mRNA copy number using the one-step nucleic acid amplification (OSNA) assay on metastatic sentinel lymph nodes (SLN) in order to identify cases at risk of having one or more positive ALN. Methods: 1296 SLN from 1080 patients were analysed with the OSNA assay. 194 patients with positive SLN underwent ALN dissection and the mean value of CK19 copy number (320 000) of their SLN was set as initial cut-off. Receiver operative characteristics curve identify a best cut-off of 7700 (sensitivity 78%, specificity 57%). A comparison between our and the traditional cut-off (5000) was performed. Results: The cut-off of 7700 successfully identifies patients with positive ALN (p=0.001, false- negative cases: 17%). In the range between 5000 and 7700, one patient with positive ALN would not undergo axillary dissection, whereas eight patients with negative ALN would be correctly identified. Conclusions: We suggest that the level of CK19 mRNA copy number could be the only parameter to consider in the intraoperative management of the axilla.

UR - http://www.scopus.com/inward/record.url?scp=84905101134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905101134&partnerID=8YFLogxK

U2 - 10.1136/jclinpath-2014-202384

DO - 10.1136/jclinpath-2014-202384

M3 - Article

VL - 67

SP - 702

EP - 706

JO - Journal of Clinical Pathology - Clinical Molecular Pathology

JF - Journal of Clinical Pathology - Clinical Molecular Pathology

SN - 0021-9746

IS - 8

ER -